LAVAL, QC, April 27 /CNW/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today
announced that its 2007 Annual Meeting of Shareholders will be held on
Wednesday, May 9, 2007 at 11:00 a.m. ET at The Montreal Museum of Fine Arts,
Maxwell Cummings Auditorium, 1379 Sherbrooke Street West Montreal, Quebec.
A live webcast of the meeting will be available at www.labopharm.com.
Please connect at least 15 minutes prior to the meeting to ensure adequate
time for any software download that may be required to join the webcast. The
webcast will be archived at the above website for 30 days.
About Labopharm Inc.
Labopharm Inc. is an international specialty pharmaceutical company
focused on the development of drugs incorporating the Company's proprietary
advanced controlled-release technologies. The Company's lead product, a
once-daily formulation of the analgesic tramadol, has been approved and
launched in Europe and is currently under review for approval by the U.S. Food
and Drug Administration. For more information, please visit www.labopharm.com.
This press release contains forward-looking statements, which reflect the
Corporation's current expectations regarding future events. The
forward-looking statements involve risks and uncertainties. Actual events
could differ materially from those projected herein and depend on a number of
factors, including the uncertainties related to the regulatory process and the
commercialization of the Corporation's products thereafter, if they are
approved. Investors should consult the Corporation's ongoing quarterly filings
and annual reports for additional information on risks and uncertainties
relating to these forward-looking statements. The reader is cautioned not to
rely on these forward-looking statements. The Corporation disclaims any
obligation to update these forward-looking statements.
For further information:
For further information: At Labopharm: Mark D'Souza, Chief Financial
Officer, Tel: (450) 686-0207; Sophie Coulombe, Manager, Legal, Corporate
Affairs and Communications, Tel: (450) 680-3221; At The Equicom Group: Jason
Hogan, Media and Investor Relations, Tel: (416) 815-0700,
firstname.lastname@example.org; French: Eric Bouchard, Tel: (514) 844-7997,